Login / Signup

Repositioning of ezetimibe for the treatment of idiopathic pulmonary fibrosis.

Chanho LeeSe Hyun KwakJisu HanJu Hye ShinByunghun YooYu Seol LeeJeong Su ParkBeom Jin LimJin Gu LeeYoung Sam KimSong Yee KimSoo Han Bae
Published in: The European respiratory journal (2024)
Our study presents ezetimibe as a potential novel therapeutic for idiopathic pulmonary fibrosis.
Keyphrases
  • idiopathic pulmonary fibrosis
  • interstitial lung disease
  • combination therapy
  • risk assessment
  • climate change